Amgen Continues to Seek Full Approval for Lumakras Cancer Drug
1 Mins read
Amgen Inc. remains committed to obtaining full approval from the Food and Drug Administration (FDA) for its Lumakras cancer drug. This comes…
FDA Warns CVS Health, Walgreens, and Others About Marketing Unapproved Eye Products
1 Mins read
The U.S. Food and Drug Administration (FDA) has issued a warning to CVS Health Corp. and Walgreens Boots Alliance Inc., along with…
Spero Therapeutics Receives FDA Approval for Phase 3 Clinical Trial of Tebipenem HBr
1 Mins read
Spero Therapeutics has obtained written agreement from the U.S. Food and Drug Administration (FDA) for a Special Protocol Assessment, which outlines the…